Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2622 (LINC02622) is a long non-coding RNA (lncRNA) gene that does not code for a protein and is classified specifically as a long intergenic non-coding RNA (lincRNA)[1][3]. LincRNAs are defined as autonomously transcribed non-coding RNA transcripts longer than 200 nucleotides that do not overlap annotated protein-coding genes[5]. While the detailed function of LINC02622 specifically has not been characterized in the literature as of now, the lincRNA family is known to be involved in the regulation of gene expression, chromatin structure, and transcription, with roles that may include enhancer-associated activity and fine-tuning expression of neighboring genes in a tissue-specific manner[5][7]. LINC02622 is not currently recognized as a therapeutic target, nor are there any known drugs or mechanism-of-action data or specific disease associations available for this RNA in current biomedical databases[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2622 (LINC02622).